Linc AB
Europe, Stockholms Lan, Sweden, Stockholm
Description
Linc AB invests in product oriented companies in the Nordic Life Science industry.
Investor Profile
Linc AB has backed more than 10 startups, with 4 new investments in the last 12 months alone. The firm has led 1 rounds, about 10% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Post Ipo Equity, Secondary Market rounds (top funding stages).
- Majority of deals are located in Sweden, Denmark.
- Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.
- Led 1 rounds in the past year.
Stage Focus
- Series Unknown (30%)
- Post Ipo Equity (20%)
- Secondary Market (10%)
- Series C (10%)
- Seed (10%)
- Post Ipo Debt (10%)
- Series B (10%)
Country Focus
- Sweden (80%)
- Denmark (20%)
Industry Focus
- Health Care
- Biotechnology
- Pharmaceutical
- Clinical Trials
- Biopharma
- Therapeutics
- Oncology
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
